Search by Drug Name or NDC
NDC 10135-0726-01 FLUPHENAZINE HYDROCHLORIDE 2.5 mg/1 Details
FLUPHENAZINE HYDROCHLORIDE 2.5 mg/1
FLUPHENAZINE HYDROCHLORIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Marlex Pharmaceuticals, Inc.. The primary component is FLUPHENAZINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Fluphenazine is an antipsychotic medication used to treat schizophrenia and psychotic symptoms such as hallucinations, delusions, and hostility. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 10135-0726-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Fluphenazine
Product Information
| NDC | 10135-0726 |
|---|---|
| Product ID | 10135-726_f5c45e2b-830b-b1ac-e053-2a95a90ac567 |
| Associated GPIs | 59200025100310 |
| GCN Sequence Number | 003825 |
| GCN Sequence Number Description | fluphenazine HCl TABLET 2.5 MG ORAL |
| HIC3 | H2G |
| HIC3 Description | ANTIPSYCHOTICS,PHENOTHIAZINES |
| GCN | 14604 |
| HICL Sequence Number | 001626 |
| HICL Sequence Number Description | FLUPHENAZINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | FLUPHENAZINE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | FLUPHENAZINE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | FLUPHENAZINE HYDROCHLORIDE |
| Labeler Name | Marlex Pharmaceuticals, Inc. |
| Pharmaceutical Class | Phenothiazine [EPC], Phenothiazines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA214674 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 10135-0726-01 (10135072601)
| NDC Package Code | 10135-726-01 |
|---|---|
| Billing NDC | 10135072601 |
| Package | 100 TABLET in 1 BOTTLE (10135-726-01) |
| Marketing Start Date | 2021-06-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |